Nu Skin Enterprises is a global company that specializes in personal care products and dietary supplements
They focus on innovating and marketing anti-aging skincare items, hair care products, and nutritional supplements through a direct selling model. The company emphasizes the use of science and technology in developing its products, which are designed to enhance the overall well-being and appearance of its customers. By combining traditional retail with a network of independent distributors, Nu Skin provides a unique shopping experience that leverages personal connections and social selling strategies.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Personal care company Nu Skin (NYSENUS) reported Q4 CY2024 results topping the market’s revenue expectations, but sales fell by 8.8% year on year to $445.6 million. On the other hand, next quarter’s revenue guidance of $355 million was less impressive, coming in 12.3% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 72.3% above analysts’ consensus estimates.
Nu Skin Enterprises, Inc. (NYSENUS) today announced its board of directors has declared a quarterly cash dividend of $0.06 per share, which will be paid on March 5, 2025, to shareholders of record on Feb. 24, 2025.
Shares of personal care company Nu Skin (NYSENUS)
jumped 13.3% in the morning session after the company reported strong preliminary Q4 2024 guidance, with revenue expected to be at the high end of the previous guidance range. A day after this report, the company is expected to share updates on its strategy, including the recent sale of Mavely for $250 million. Overall, the updates provide more reasons for investors to stay optimistic.
Nu Skin Enterprises Inc. (NYSENUS) today announced Q4 2024 preliminary revenue at the high end of the company’s guidance range ahead of its presentation at the ICR Conference on Tuesday, Jan. 14. President and CEO Ryan Napierski and CFO James Thomas will participate in a moderated fireside chat to discuss company strategy and the state of the business, including the recent strategic transaction of Mavely for $250 million.
Shares of personal care company Nu Skin (NYSENUS)
jumped 21.9% in the morning session after the company announced the sale of the Mavely affiliate technology platform, owned by its subsidiary Rhyz Inc., to Later, a marketing and social media management software firm. Valued at $250 million, the deal delivered a substantial payoff, with management adding, "This transaction yielded roughly a fivefold return on the company's total investment in Mavely since its acquisition in 2021."
Nu Skin Enterprises Inc. (NYSENUS) today announced that its Rhyz Inc. subsidiary completed a strategic transaction with Later, a portfolio company of Summit Partners. As part of the transaction, Rhyz sold its Mavely affiliate marketing technology platform to Later in exchange for approximately $250 million in the form of cash and a minority equity stake in the combined Later/Mavely business. Approximately $33 million of such consideration will be paid to other equity holders in the Mavely business. In connection with the transaction, Mavely is expected to continue to provide certain technology and social commerce capabilities to support Nu Skin’s affiliate marketing business.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Inter Parfums (NASDAQIPAR) and the rest of the personal care stocks fared in Q3.
Looking back on personal care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Edgewell Personal Care (NYSEEPC) and its peers.
